Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

822 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Rituximab for rheumatoid arthritis refractory to anti-tumor necrosis factor therapy: Results of a multicenter, randomized, double-blind, placebo-controlled, phase III trial evaluating primary efficacy and safety at twenty-four weeks.
Cohen SB, Emery P, Greenwald MW, Dougados M, Furie RA, Genovese MC, Keystone EC, Loveless JE, Burmester GR, Cravets MW, Hessey EW, Shaw T, Totoritis MC; REFLEX Trial Group. Cohen SB, et al. Among authors: burmester gr. Arthritis Rheum. 2006 Sep;54(9):2793-806. doi: 10.1002/art.22025. Arthritis Rheum. 2006. PMID: 16947627 Clinical Trial.
p205 is a major target of autoreactive T cells in rheumatoid arthritis.
Bläss S, Schumann F, Hain NA, Engel JM, Stuhlmüller B, Burmester GR. Bläss S, et al. Among authors: burmester gr. Arthritis Rheum. 1999 May;42(5):971-80. doi: 10.1002/1529-0131(199905)42:5<971::AID-ANR16>3.0.CO;2-A. Arthritis Rheum. 1999. PMID: 10323453
A Phase III Study Evaluating Continuation, Tapering, and Withdrawal of Certolizumab Pegol After One Year of Therapy in Patients With Early Rheumatoid Arthritis.
Weinblatt ME, Bingham CO 3rd, Burmester GR, Bykerk VP, Furst DE, Mariette X, van der Heijde D, van Vollenhoven R, VanLunen B, Ecoffet C, Cioffi C, Emery P. Weinblatt ME, et al. Among authors: burmester gr. Arthritis Rheumatol. 2017 Oct;69(10):1937-1948. doi: 10.1002/art.40196. Epub 2017 Sep 12. Arthritis Rheumatol. 2017. PMID: 28666080 Free PMC article. Clinical Trial.
Efficacy and safety of rituximab treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitides: results from a German registry (GRAID).
Roll P, Ostermeier E, Haubitz M, Lovric S, Unger L, Holle J, Kötter I, Henes JC, Bergner R, Rubbert-Roth A, Specker C, Schulze-Koops H, Müller-Ladner U, Fleck M, Burmester GR, Hiepe F, Heitmann S, Aringer M, Fischer-Betz R, Dörner T, Tony HP. Roll P, et al. Among authors: burmester gr. J Rheumatol. 2012 Nov;39(11):2153-6. doi: 10.3899/jrheum.120482. Epub 2012 Sep 15. J Rheumatol. 2012. PMID: 22984269
Persistent clinical efficacy and safety of infliximab in ankylosing spondylitis after 8 years--early clinical response predicts long-term outcome.
Baraliakos X, Listing J, Fritz C, Haibel H, Alten R, Burmester GR, Krause A, Schewe S, Schneider M, Sörensen H, Schmidt R, Sieper J, Braun J. Baraliakos X, et al. Among authors: burmester gr. Rheumatology (Oxford). 2011 Sep;50(9):1690-9. doi: 10.1093/rheumatology/ker194. Epub 2011 Jun 14. Rheumatology (Oxford). 2011. PMID: 21672969
Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial.
Fleischmann RM, Schechtman J, Bennett R, Handel ML, Burmester GR, Tesser J, Modafferi D, Poulakos J, Sun G. Fleischmann RM, et al. Among authors: burmester gr. Arthritis Rheum. 2003 Apr;48(4):927-34. doi: 10.1002/art.10870. Arthritis Rheum. 2003. PMID: 12687534 Clinical Trial.
sE-selectin for stratifying outcome in rheumatoid arthritis.
Egerer K, Hertzer J, Feist E, Albrecht A, Rudolph PE, Dörner T, Burmester GR. Egerer K, et al. Among authors: burmester gr. Arthritis Rheum. 2003 Aug 15;49(4):546-8. doi: 10.1002/art.11190. Arthritis Rheum. 2003. PMID: 12910562
822 results